Haemodialysis — Potassium in Haemodialysis Fluids and Haemodynamics
Citation(s)
Amberg GC, Bonev AD, Rossow CF, Nelson MT, Santana LF Modulation of the molecular composition of large conductance, Ca(2+) activated K(+) channels in vascular smooth muscle during hypertension. J Clin Invest. 2003 Sep;112(5):717-24.
Bia MJ, DeFronzo RA Extrarenal potassium homeostasis. Am J Physiol. 1981 Apr;240(4):F257-68. Review.
Fernandez J, Oster JR, Perez GO Impaired extrarenal disposal of an acute oral potassium load in patients with endstage renal disease on chronic hemodialysis. Miner Electrolyte Metab. 1986;12(2):125-9.
Gabutti L, Bianchi G, Soldini D, Marone C, Burnier M Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids. Nephrol Dial Transplant. 2009 Mar;24(3):973-81. doi: 10.1093/ndt/gfn541. Epub 2008 Oct 8.
Haddy FJ, Vanhoutte PM, Feletou M Role of potassium in regulating blood flow and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R546-52. Review.
Kim MJ, Song Jh, Kim Ga, Lim Hj, Lee Sw Optimization of dialysate sodium in sodium profiling haemodialysis. Nephrology (Carlton). 2003 Oct;8 Suppl:S16-22. Review.
Musso CG Potassium metabolism in patients with chronic kidney disease. Part II: patients on dialysis (stage 5). Int Urol Nephrol. 2004;36(3):469-72. Review.
Rastegar A, Soleimani M Hypokalaemia and hyperkalaemia. Postgrad Med J. 2001 Dec;77(914):759-64. Review. Erratum in: Postgrad Med J 2002 Feb;78(916):126. Rastergar A [corrected to Rastegar A].
Rodrigo F, Shideman J, McHugh R, Buselmeier T, Kjellstrand C Osmolality changes during hemodialysis. Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol. Ann Intern Med. 1977 May;86(5):554-61.
Selby NM, McIntyre CW A systematic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant. 2006 Jul;21(7):1883-98. Epub 2006 Apr 6. Review.
Sulowicz W, Radziszewski A Dialysis induced hypotension--a serious clinical problem in renal replacement therapy. Med Pregl. 2007;60 Suppl 2:14-20. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
